Drug Type Small molecule drug |
Synonyms NB 533, NB533 |
Target |
Action inhibitors |
Mechanism BACE1 inhibitors(Beta-secretase 1 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC33H55N3O4 |
InChIKeyMNENNUUKHSBOKZ-BEOVBFIISA-N |
CAS Registry1146544-18-4 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Alzheimer Disease | Preclinical | Switzerland | 01 Mar 2009 |





